Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...
JOHANNESBURG (Reuters) -Aspen Pharmacare reported a 5% rise in half-year earnings on Monday and said it expects double-digit ...
Explore how weight loss injections like Ozempic and Mounjaro can impact your libido, from boosting confidence to potential ...
Analysis of Aspen Pharmacare's H1 2025 results. Revenue up, EBITDA strong, focus on GLP-1s & sterile manufacturing. Learn ...
Mounjaro (tirzepatide) is a brand-name injection prescribed for type 2 diabetes in adults. As with other drugs, Mounjaro can cause side effects, such as nausea, diarrhea, and appetite loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results